ConductScience.org, home

Paper7654479

Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole.

van der Ven AJ and 4 others. Br J Clin Pharmacol, 1995. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole. Papers, record 7654479. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7654479

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
1.74
iCite
Revised in PubMed
2019-05-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van der Ven AJA J
2Vree TBT B
3van Ewijk-Beneken Kolmer EWE W
4Koopmans PPP P
5van der Meer JWJ W

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV SeropositivityMajor topic
SulfamethoxazoleMajor topic
Adult
Dose-Response Relationship, Drug
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13521428Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial.Ann Intern Med1986https://conductscience.org/library/papers/3521428PubMed
27820261Isolation, identification and determination of sulfamethoxazole and its known metabolites in human plasma and urine by high-performance liquid chromatography.J Chromatogr B Biomed Appl1994https://conductscience.org/library/papers/7820261PubMed
36138645Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men.Lancet1983https://conductscience.org/library/papers/6138645PubMed
46230976Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.Ann Intern Med1984https://conductscience.org/library/papers/6230976PubMed
56231873Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.Ann Intern Med1984https://conductscience.org/library/papers/6231873PubMed
63873229The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.Arch Intern Med1985https://conductscience.org/library/papers/3873229PubMed
74075255In vitro evaluation of a toxic metabolite of sulfadiazine.Can J Physiol Pharmacol1985https://conductscience.org/library/papers/4075255PubMed
82870332Serum trimethoprim and sulphamethoxazole levels in AIDS.Lancet1986https://conductscience.org/library/papers/2870332PubMed
93346843Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.J Pharmacol Exp Ther1988https://conductscience.org/library/papers/3346843PubMed
103260759Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study.Ann Intern Med1988https://conductscience.org/library/papers/3260759PubMed
112913915Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites.Ann Intern Med1989https://conductscience.org/library/papers/2913915PubMed
122784648Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions.Ann Intern Med1989https://conductscience.org/library/papers/2784648PubMed
132784973Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients.Biol Chem Hoppe Seyler1989https://conductscience.org/library/papers/2784973PubMed
142574255Systemic glutathione deficiency in symptom-free HIV-seropositive individuals.Lancet1989https://conductscience.org/library/papers/2574255PubMed
152392131Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.N Engl J Med1990https://conductscience.org/library/papers/2392131PubMed
161678095Adverse reactions to co-trimoxazole in HIV infection.Lancet1991https://conductscience.org/library/papers/1678095PubMed
171686233Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.Drug Metab Dispos1991https://conductscience.org/library/papers/1686233PubMed
181587066Sulfamethoxazole is metabolized to the hydroxylamine in humans.Clin Pharmacol Ther1992https://conductscience.org/library/papers/1587066PubMed
191617949MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring.Comput Biol Med1992https://conductscience.org/library/papers/1617949PubMed
207981016Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole.Br J Clin Pharmacol1994https://conductscience.org/library/papers/7981016PubMed

See all 21 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
41344065N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation.Drug Metab Dispos2025https://conductscience.org/library/papers/41344065PubMed
30734913Fate of 14C-acetyl sulfamethoxazole during the activated sludge process.Environ Sci Pollut Res Int2019https://conductscience.org/library/papers/30734913PubMed
28603631Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.Pharmacol Res Perspect2017https://conductscience.org/library/papers/28603631PubMed
16603214Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.Toxicol Appl Pharmacol2006https://conductscience.org/library/papers/16603214PubMed
11600390Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11600390PubMed
11350866Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.Br J Pharmacol2001https://conductscience.org/library/papers/11350866PubMed
9010640Role of viral infections in the induction of adverse drug reactions.Drug Saf1997https://conductscience.org/library/papers/9010640PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7654479

GET https://conductscience.org/api/papers/v1/7654479/references?page=2